March 14, 2024 | By Michelle Jones | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events
Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …
March 14, 2024 | By Michelle Jones | News & Events, Clinical Trials, Liver, Liver Disease, Liver Health, NASH | Promising Advance in Treatment, resmetirom, Rezdiffra
Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and growing challenge in clinical practice, with its progression to cirrhosis and hepatocellular carcinoma posing serious risks for patients. The exciting new conditional commercial launch of …
February 24, 2023 | By John Raslavsky | Liver, NASH | Blog, Clinical trials, Fatty Liver Disease, Fibroscan, Liver disease, liver health
Obesity has become one of the most common and serious public health issues in recent years, leading to many health problems. Yet, many remain unaware of the consequences of obesity on the liver. Learn more in our blog below! Excess …
July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …
November 24, 2020 | By John Raslavsky | Clinical Trials, NAFLD, NASH | Blog, fatty liver, Fibroscan
Every liver has a small amount of fat in it. With fatty liver, unhealthy fat levels begin to accumulate, leading to liver damage if not treated. There are various types of fatty liver disease, but NAFLD (non-alcoholic fatty liver …